SEC Form 4 · accession 0001209191-15-064776
OPKO HEALTH, INC. · OPK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Phillip Md Et Al Frost
Officer — CEO & Chairman · Director · 10% Owner
Frost Gamma Investments Trust
10% Owner
Period of report
Aug 7, 2015
Accepted (ET)
Aug 10, 2015 · 8:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2015 | M | 112,500 | $2.36 | A | 2,124,877 | D | |
| Common Stock | Aug 7, 2015 | M | 250,000 | $7.61 | A | 2,374,877 | D | |
| Common Stock | Aug 7, 2015 | M | 54,730 | $5.50 | A | 2,429,607 | D | |
| Common Stock | Aug 7, 2015 | M | 539,344 | $4.77 | A | 2,968,951 | D | |
| Common Stock | Aug 7, 2015 | M | 100,000 | $8.37 | A | 3,068,951 | D | |
| Common StockF1 | holding | — | — | — | 156,015,068 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 20,091,062 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.36 | Aug 7, 2015 | M | 112,500 | D | — | Apr 13, 2017 | Common Stock | 112,500 | 0 | D |
| Stock Option (Right to Buy)F4 | $7.61 | Aug 7, 2015 | M | 250,000 | D | — | Mar 17, 2020 | Common Stock | 250,000 | 250,000 | D |
| Stock Option (Right to Buy) | $4.77 | Aug 7, 2015 | M | 539,344 | D | Aug 29, 2013 | Feb 4, 2023 | Common Stock | 539,344 | 0 | D |
| Stock Option (Right to Buy) | $5.50 | Aug 7, 2015 | M | 54,730 | D | Aug 4, 2012 | Aug 4, 2021 | Common Stock | 54,730 | 0 | D |
| Stock Option (Right to Buy)F5 | $8.37 | Aug 7, 2015 | M | 100,000 | D | — | Apr 13, 2024 | Common Stock | 100,000 | 300,000 | D |
Explanation of responses
- F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2These securities are owned directly by The Frost Group, LLC. Frost Gamma Investments Trust is a principal member of The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3The options were granted on April 14, 2010 and vested in four equal installments beginning on April 14, 2011.
- F4The options were granted on March 18, 2013 and vest in four equal installments beginning on March 18, 2014.
- F5The options were granted on April 14, 2014 and vest in four equal installments beginning on April 14, 2015.